Search research articles
Contact Us
Filters
Showing results (91-100 of 346) with videos related to
Page
of 35
Sort By:
Journal of Cancer Survivorship : Research and Practice
|
November 7, 2023
Improve the management of cancer-related cognitive impairment in clinical settings: a European Delphi study
Mylène Duivon, Marie Lange, Giulia Binarelli, et al.
Bulletin Du Cancer
|
September 22, 2020
[Nice-Saint-Paul de Vence 2020 recommendations for clinical practice: Management of metastatic and/or relapsing endometrial cancer]
Jérôme Alexandre, Marie Aude Le Frere-Belda, Karine Prulhiere, et al.
American Journal of Clinical Oncology
|
August 8, 2006
Phase I study of pegylated liposomal doxorubicin in combination with ifosfamide in pretreated ovarian cancer patients
Hugues Bourgeois, Florence Joly, Eric Pujade-Lauraine, et al.
Health and Quality of Life Outcomes
|
December 8, 2016
Cross-cultural adaptation and validation of the French version of the Expanded Prostate cancer Index Composite questionnaire for health-related quality of life in prostate cancer patients
Amélie Anota, Anne-Sophie Mariet, Philippe Maingon, et al.
Gynecologic Oncology
|
January 30, 2010
Phase II study of gefitinib in combination with paclitaxel (P) and carboplatin (C) as second-line therapy for ovarian, tubal or peritoneal adenocarcinoma (1839IL/0074)
Patricia Pautier, Florence Joly, Pierre Kerbrat, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 24, 2014
Quality of life research in endometrial cancer: what is needed to advance progress in this disease site? Methodological considerations from the Gynecologic Cancer InterGroup Symptom Benefit Working Group brainstorming session, Leiden 2012
Jessica N McAlpine, Elfriede Greimel, Lori A Brotto, et al.
Bulletin Du Cancer
|
March 30, 2019
[Antineoplastic drug induced nausea and vomiting: What is the clinical practice in 2018? An update of AFSOS clinical guidelines]
Nicolas Jovenin, Audrey Eche-Gass, Stéphane Chèze, et al.
Bulletin Du Cancer
|
January 30, 2026
[Recommendations for clinical practice Nice-Saint Paul de Vence 2024-2025 - Cardio-oncological management of the main therapeutic regimens in onco-gynecology]
Olivia Le Saux, Elvire Mervoyer, Laura Deiana, et al.
Cancer Chemotherapy and Pharmacology
|
July 6, 2017
Association of NR1I2, CYP3A5 and ABCB1 genetic polymorphisms with variability of temsirolimus pharmacokinetics and toxicity in patients with metastatic bladder cancer
Litaty C Mbatchi, Matthieu Gassiot, Philippe Pourquier, et al.
Cancers
|
July 24, 2021
The Prostate Cancer Therapy Enzalutamide Compared with Abiraterone Acetate/Prednisone Impacts Motivation for Exploration, Spatial Learning and Alters Dopaminergic Transmission in Aged Castrated Mice
Celeste Nicola, Martine Dubois, Cynthia Campart, et al.
Page
of 35
Search research articles
Search
Showing results (91-100 of 346) with videos related to
Sort By:
Page
of 35
Journal of Cancer Survivorship : Research and Practice
|
November 7, 2023
Improve the management of cancer-related cognitive impairment in clinical settings: a European Delphi study
Mylène Duivon, Marie Lange, Giulia Binarelli, et al.
Bulletin Du Cancer
|
September 22, 2020
[Nice-Saint-Paul de Vence 2020 recommendations for clinical practice: Management of metastatic and/or relapsing endometrial cancer]
Jérôme Alexandre, Marie Aude Le Frere-Belda, Karine Prulhiere, et al.
American Journal of Clinical Oncology
|
August 8, 2006
Phase I study of pegylated liposomal doxorubicin in combination with ifosfamide in pretreated ovarian cancer patients
Hugues Bourgeois, Florence Joly, Eric Pujade-Lauraine, et al.
Health and Quality of Life Outcomes
|
December 8, 2016
Cross-cultural adaptation and validation of the French version of the Expanded Prostate cancer Index Composite questionnaire for health-related quality of life in prostate cancer patients
Amélie Anota, Anne-Sophie Mariet, Philippe Maingon, et al.
Gynecologic Oncology
|
January 30, 2010
Phase II study of gefitinib in combination with paclitaxel (P) and carboplatin (C) as second-line therapy for ovarian, tubal or peritoneal adenocarcinoma (1839IL/0074)
Patricia Pautier, Florence Joly, Pierre Kerbrat, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
October 24, 2014
Quality of life research in endometrial cancer: what is needed to advance progress in this disease site? Methodological considerations from the Gynecologic Cancer InterGroup Symptom Benefit Working Group brainstorming session, Leiden 2012
Jessica N McAlpine, Elfriede Greimel, Lori A Brotto, et al.
Bulletin Du Cancer
|
March 30, 2019
[Antineoplastic drug induced nausea and vomiting: What is the clinical practice in 2018? An update of AFSOS clinical guidelines]
Nicolas Jovenin, Audrey Eche-Gass, Stéphane Chèze, et al.
Bulletin Du Cancer
|
January 30, 2026
[Recommendations for clinical practice Nice-Saint Paul de Vence 2024-2025 - Cardio-oncological management of the main therapeutic regimens in onco-gynecology]
Olivia Le Saux, Elvire Mervoyer, Laura Deiana, et al.
Cancer Chemotherapy and Pharmacology
|
July 6, 2017
Association of NR1I2, CYP3A5 and ABCB1 genetic polymorphisms with variability of temsirolimus pharmacokinetics and toxicity in patients with metastatic bladder cancer
Litaty C Mbatchi, Matthieu Gassiot, Philippe Pourquier, et al.
Cancers
|
July 24, 2021
The Prostate Cancer Therapy Enzalutamide Compared with Abiraterone Acetate/Prednisone Impacts Motivation for Exploration, Spatial Learning and Alters Dopaminergic Transmission in Aged Castrated Mice
Celeste Nicola, Martine Dubois, Cynthia Campart, et al.
Page
of 35